Recent FDA approvals and changes.
D000225:Adenine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000293:Adolescent; D000328:Adult; D019380:Anti-HIV Agents; D002648:Child; D003692:Delayed-Action Preparations; D016049:Didanosine; D017277:Drug Approval; D004348:Drug Labeling; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D006801:Humans; D063065:Organophosphonates / Q000008:administration & dosage / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D000068698:Tenofovir; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D003692:Delayed-Action Preparations; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine; D016049:Didanosine